We are live on ! Find out more
EWA

Exencial Wealth Advisors Portfolio holdings

AUM $3.22B
1-Year Est. Return 20.17%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+20.17%
3 Year Est. Return
+57.98%
5 Year Est. Return
+67.51%
10 Year Est. Return
+365.34%
AUM
$236M
AUM Growth
+$10.3M
Cap. Flow
-$1.81M
Cap. Flow %
-0.77%
Top 10 Hldgs %
27.37%
Holding
180
New
17
Increased
51
Reduced
75
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 11.8%
2 Technology 10.48%
3 Healthcare 10.3%
4 Energy 8.17%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
151
Regeneron Pharmaceuticals
REGN
$72.9B
$217K 0.09%
590
INCY icon
152
Incyte
INCY
$25.4B
$215K 0.09%
+2,140
New +$209K
MDLZ icon
153
Mondelez International
MDLZ
$83.4B
$212K 0.09%
4,790
-87
-2% -$3.75K
EWL icon
154
iShares MSCI Switzerland ETF
EWL
$2.17B
$208K 0.09%
7,072
-547
-7% -$16K
EIS icon
155
iShares MSCI Israel ETF
EIS
$863M
$206K 0.09%
4,430
+13
+0.3% +$607
CAG icon
156
Conagra Brands
CAG
$7.42B
$205K 0.09%
5,180
-1,476
-22% -$55.2K
OPK icon
157
Opko Health
OPK
$1.02B
$205K 0.09%
22,000
+2,000
+10% +$20.7K
TIP icon
158
iShares TIPS Bond ETF
TIP
$14.5B
$204K 0.09%
+1,806
New +$206K
ABBV icon
159
AbbVie
ABBV
$465B
$203K 0.09%
+3,247
New +$198K
CHRD icon
160
Chord Energy
CHRD
$7.68B
$189K 0.08%
12,500
FSK icon
161
FS KKR Capital
FSK
$3.01B
$151K 0.06%
3,665
ANGI icon
162
Angi Inc
ANGI
$247M
$123K 0.05%
1,500
-1,500
-50% -$128K
TCRT icon
163
Alaunos Therapeutics
TCRT
$4.64M
$82K 0.03%
+102
New +$91.9K
TEAR
164
DELISTED
TearLab Corporation
TEAR
$64K 0.03%
12,217
-1,000
-8% -$5.68K
BCRX icon
165
BioCryst Pharmaceuticals
BCRX
$2.42B
$63K 0.03%
+10,000
New +$52K
SGYP
166
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$61K 0.03%
+10,000
New +$52.3K
MACK
167
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$61K 0.03%
+1,907
New +$81.3K
GLUU
168
DELISTED
Glu Mobile Inc.
GLUU
$49K 0.02%
+25,000
New +$52.4K
NAVB
169
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$19K 0.01%
+1,500
New +$23.8K
CNC icon
170
Centene
CNC
$30.5B
-8,920
Closed -$279K
EFO icon
171
ProShares Ultra MSCI EAFE
EFO
$29.1M
-7,299
Closed -$210K
FLR icon
172
Fluor
FLR
$6.54B
-56,195
Closed -$2.92M
ORCL icon
173
Oracle
ORCL
$339B
-5,802
Closed -$223K
SBUX icon
174
Starbucks
SBUX
$119B
-6,143
Closed -$326K
V icon
175
Visa
V
$701B
-2,631
Closed -$217K

Similar funds

Exencial Wealth Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Exencial Wealth Advisors held 180 positions worth $236M, up 4.5% from $226M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Exencial Wealth Advisors's Q4 2016 filing shows 17 new, 51 increased, 75 reduced and 11 closed positions. Its largest new stake was Vanguard Total Bond Market: 29,972 shares worth $2.42M. The largest sale was Fluor, an estimated $2.92M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • Exencial Wealth Advisors's largest Q4 2016 buy was Vanguard Total Bond Market: 29,972 shares worth $2.42M.
  • Exencial Wealth Advisors added most to iShares Global Healthcare ETF in Q4 2016, an estimated $2.4M increase.
  • Exencial Wealth Advisors's biggest Q4 2016 reduction was Novartis, cutting an estimated $1.35M.
  • Exencial Wealth Advisors fully exited Fluor in Q4 2016, selling an estimated $2.92M.
  • Exencial Wealth Advisors's ten largest holdings make up 27% of its $236M portfolio in Q4 2016.
  • Exencial Wealth Advisors opened 17 new positions and closed 11 in Q4 2016.
  • Exencial Wealth Advisors's portfolio value rose 4.5% quarter-over-quarter to $236M.

Based on Exencial Wealth Advisors's 13F filing for Q4 2016, filed 20 Jan 2017.